Frontlight ResearchEarly access
Trial site
Providence Cancer Center
- 5running trials
- 1closed trial
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Acute myeloid leukaemia1 trial
- Colorectal cancer1 trial
- Melanoma1 trial
- Myelodysplastic syndromes1 trial
- Myeloproliferative neoplasms1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 23 trials
- Phase 1/22 trials
- Status
- Active, not recruiting4 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Providence Health & Services3 trials
- Celgene1 trial
- Cullinan Therapeutics Inc.1 trial
- Janssen Research & Development, LLC1 trial
Running trials
Recruiting
Active, not recruiting
A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer
Active, not recruiting
Active, not recruiting
Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
Closed trials
Terminated
Site data: ClinicalTrials.govUpdated 12 Nov 2026